CONTACT
+91 80 2808 2808
info@biocon.com
Inside Banner
Biocon  /  About Us  /  Who we are

OVERVIEW

Who we are

A Global Pioneer

Our pioneering spirit paved the way for biotechnology in India, and we continue to apply the same spirit in finding novel approaches to improve patient outcomes today for a better tomorrow. This drives us to continuously find new ways to treat diabetes, cancer and autoimmune diseases. Our R&D focuses on prevention, alleviation and treatment and our medicines improve the lives of millions of patients in over 120 countries, by giving them access to life-saving therapies and relief.

null

We are a global biopharmaceutical company which believes that everyone has a right to affordable quality medicines.

null

From pipeline to production, from drug discovery to drug delivery, we bring differentiated, high-quality and affordable healthcare products to global communities.

What we do

We aim to achieve health equity.

Powered by advanced therapy platforms, our 12,000+ employees blend heart, science and creativity to make better healthcare solutions.

Our 4 global businesses include generics, biosimilars, research services and novel biologics. They represent Biocon’s risk-balanced strategy, underpinned by agile network connections, a robust pipeline and a timely ‘emerging markets’ orientation. We have leveraged India’s value advantage of unmatched scientific talent and cost-competitive manufacturing to deliver scale, speed and quality. By making medicines more easily accessible for patients across the globe, we’re working towards achieving health equity.

Our purpose

We are committed to providing everyone, everywhere, affordable access to a speciality portfolio of medicines.

We are steadfastly investing in developing novel therapies for diabetes, oncology and immunology. We are strengthening our global reach and economies of scale.

Corporate Overview

Download
Our Annual Report 2020 The Impact Manifesto

Touching a billion lives through affordable innovation

Our Businesses

Path-breaking offerings. Far reaching impact.
GENERICS-biocon

GENERICS

BIOSIMILARS-biocon

BIOSIMILARS

RESEARCH-SERVICES-biocon

RESEARCH SERVICES

NOVEL-BIOLOGICS-biocon

NOVEL BIOLOGICS

Factsheet

Biocon at a glance
Advancing
biotechnology for
40+
years
Improving lives
across
120+
countries
Talented, dedicated
workforce of
12,000+
employees

Factsheet

Biocon at a glance
Advancing
biotechnology for
40+
years
Improving lives
across
120+
countries
Talented, dedicated
workforce of
12,000+
employees

A culture of innovation

Biocon at a glance
276
Patents Granted
(Small Molecules)
Till end of FY 20
891
Patents Granted
(Biologics)
Till end of FY 20
25+
cGMP Approvals
international
regulatory agencies
7
Biologics were taken
from 'Lab to Market':
2 Novels and
5 Biosimilars
vision-biocon

vision

To enhance global healthcare through innovative and affordable biopharmaceuticals for patients, partners and healthcare systems across the globe.

values-biocon

values

Integrity and ethical behaviour

Performance-driven work culture

Value creation through innovation and differentiation

Quality through compliance and best practices

Collaboration, teamwork and mutual respect

mission-biocon

mission

To be an integrated biotechnology enterprise of  global distinction. Essential to this mission is excellence in:

Intellectual asset creation through discovery, research and development

State-of-the-art manufacturing capabilities

Internationally benchmarked quality and regulatory systems

New medical insight through disease-specific clinical research

Customer relationship through outstanding products and services

Human resource development through training, mentoring and empowering

Management of research and business partnerships

CORPORATE GOVERNANCE
KEY THERAPEUTIC AREAS
RESEARCH SERVICES
OUR CULTURE
RESPONSIBILITY
Share